Skip to main content
PLOS One logoLink to PLOS One
. 2023 May 10;18(5):e0284570. doi: 10.1371/journal.pone.0284570

Metabolomics during canine pregnancy and lactation

Sebastian P Arlt 1,2,*, Claudia Ottka 3, Hannes Lohi 3,4,5, Janna Hinderer 2, Julia Lüdeke 2, Elisabeth Müller 6, Corinna Weber 6, Barbara Kohn 7, Alexander Bartel 8,*
Editor: Mükremin Ölmez9
PMCID: PMC10171673  PMID: 37163464

Abstract

During pregnancy and parturition, female dogs have to cope with various challenges such as providing nutrients for the growth of the fetuses, hormonal changes, whelping, nursing, milk production, and uterine involution. Metabolomic research has been used to characterize the influence of several factors on metabolism such as inter- and intra-individual factors, feeding, aging, inter-breed differences, drug action, behavior, exercise, genetic factors, neuter status, and pathologic processes. Aim of this study was to identify metabolites showing specific changes in blood serum at the different phases of pregnancy and lactation. In total, 27 privately owned female dogs of 21 different breeds were sampled at six time points: during heat, in early, mid and late pregnancy, at the suspected peak of lactation and after weaning. A validated and highly automated canine-specific NMR metabolomics technology was utilized to quantitate 123 measurands. It was evaluated which metabolite concentrations showed significant changes between the different time points. Metabolites were then grouped into five clusters based on concentration patterns and biochemical relationships between the metabolites: high in mid-pregnancy, low in mid-pregnancy, high in late pregnancy, high in lactation, and low in lactation. Several metabolites such as albumin, glycoprotein acetyls, fatty acids, lipoproteins, glucose, and some amino acids show similar patterns during pregnancy and lactation as shown in humans. The patterns of some other parameters such as branched-chain amino acids, alanine and histidine seem to differ between these species. For most metabolites, it is yet unstudied whether the observed changes arise from modified resorption from the intestines, modified production, or metabolism in the maternal or fetal tissues. Hence, further species-specific metabolomic research may support a broader understanding of the physiological changes caused by pregnancy that are likely to be key for the normal fetal growth and development. Our findings provide a baseline of normal metabolic changes during healthy canine pregnancy and parturition. Combined with future metabolomics findings, they may help monitor vital functions of pre-, intra-, and post-partum bitches and may allow early detection of illness.

Introduction

Pregnancy and parturition are challenging for mammals because they are characterized by considerable hormonal and metabolic changes [1, 2] to support fetal demands [3, 4]. During pregnancy the maternal body needs to supply appropriate nutrients for the conceptuses via the placentas and later the newborn puppies rely on lactation for several weeks [5]. These processes are governed by complex hormonal and neurological interactions and cause major alterations in the mothers metabolism [5], resulting in modified nutritional demands for both micro- and macronutrients [6, 7]. It has been claimed that even small deviations of the metabolism from the norm during pregnancy could have serious consequences for the mother and the offspring [8].

In dogs, pregnancy-related changes in metabolic parameters might be even more intensive than in many other mammalian species because fetal development is rapid as pregnancy duration is, on average, only 63 days, and a bitch might carry a high number of conceptuses. Parturition usually lasts several hours, is laborious, and often exhausting [9]. Other parameters may change during pregnancy and parturition because of hormonal changes, uterine enlargement, pain, anxiety and uterine contractions [10]. In addition, the canine endotheliochorial placentation type leads to a longer and more intensive uterine involution process than in other species [11]. Finally, also tasks such as nursing the puppies, including milk production and change of diet, are challenging for the female dog [1].

Understanding the physiology, endocrinology, and metabolic features during pregnancy, parturition, and lactation are required to understand and diagnose normal and abnormal conditions and provide optimal supportive management [1, 5]. In that regard, it is important to realize that some parameters change physiologically during pregnancy, parturition, and lactation [10]. However, it has been shown that inadequate supply of key metabolites can lead to abnormal fetal growth and impaired development of organs such as the heart [12] or nerval tissue [13].

Metabolomics is an omics-based approach that generates comprehensive information about metabolites in blood serum, enabling an extensive view of the individual’s current state of systemic metabolism [14, 15]. Several metabolomics studies have been conducted in humans to address the physiological and pathophysiological metabolic changes during pregnancy and lactation, but no previous studies have been conducted in dogs. This study aimed to determine the metabolic changes occurring in dogs during pregnancy and lactation, to discuss their similarities or differences to the changes occurring in humans.

Materials and methods

Animals

In total, 27 privately owned bitches of 21 different breeds were sampled during this study (Table 1). Female dogs were enrolled from March 2018 until December 2019. To be included, bitches had to be generally healthy within the past 6 months before mating and not receive medication, except deworming. In addition, dogs had to become pregnant and be presented for sampling at six time-points. Previous gynecological illnesses were inquired about, but none were present in any of the bitches at the time of sampling. Informed written consent and approval from the owners was obtained. The dogs were fed individual diets chosen by the owners. The blood sample collection was approved by the committee on animal welfare of the federal state Berlin (LAGeSo Berlin O 0095/18).

Table 1. Attributes of female dogs included in a study on metabolomics during canine pregnancy and lactation.

Dog No Breed Bodyweight (kg) Parity* Age Number of puppies born Thereof stillborn puppies
1 Dogue de Bordeaux 51.3 4 7.0 2 0
2 Miniature Bull Terrier 16.8 1 2.9 6** 3
3 Rhodesian Ridgeback 38.0 2 4.9 12 1
4 Saarloos Wolfhound 28.8 2 6.2 5 0
5 Collie 24.0 2 6.3 5 0
6 Borzoi 36.4 1 8.1 8** 0
7 Labrador Retriever 22.4 1 2.6 9 0
8 Staffordshire Bull Terrier 14.2 1 2.6 1 0
9 French Bulldog 11.8 2 2.6 3 1
10 Schnauzer 18.2 2 7.8 6 0
11 Olde English Bulldogge 32.2 1 2.0 12 1
12 Miniature Bull Terrier 19.0 2 4.7 7** 0
13 Wirehaired Dachshund 9.0 2 4.9 7 0
14 Boxer 27.8 2 6.8 4 0
15 Hovawart 41.6 2 6.7 9 1
16 Irish Wolfhound 56.4 1 2.9 13 1
17 Golden Retriever 22.8 1 4.4 5 0
18 Entlebucher Mountain Dog 23.6 1 2.6 7 0
19 Golden Retriever 33.0 1 4.6 6 0
20 Miniature Bull Terrier 16.0 2 5.4 6 1
21 Eurasier 20.8 2 3.8 5 0
22 Wirehaired Dachshund 9.2 1 3.4 6 0
23 Kromfohrlaender 10.4 1 2.9 7 1
24 English Cocker Spaniel 11.2 2 2.9 8 0
25 Labrador Retriever 28.2 2 5.3 6 0
26 English Cocker Spaniel 11.2 2 2.9 6 0
27 Dobermann 38.8 1 3.4 13 0
Total (Average) 24.9 1.6 4.5 6.8 0.37

* including the current pregnancy,

** these dogs underwent C-section

Bitches were initially presented for ovulation timing. After they met the inclusion criteria, an initial clinical and gynecological examination was performed, including vaginoscopy and vaginal cytology.

Blood sampling and sample processing

For this study, three stages of canine pregnancy were defined according to Hinderer et al. [16]. A total of six appointments for drawing blood samples were scheduled. The first sample was taken at a visit for ovulation timing in estrus (E). Three samplings during pregnancy (P) were appointed, i. e., between day 11 and 19 (P1) after mating, between day 23 and day 32 (P2), and between day 52 and 60 (P3). The P2 examination included an ultrasonic examination to assert whether the bitch was pregnant. This examination was not scheduled in the middle of the second third to respect the owners’ wishes of having a pregnancy diagnosis rather sooner than later while completing the study examination within the same appointment. A fifth sampling was performed 18 to 24 days after whelping. The last clinical examination (A) was performed 18 to 24 days after the weaning of the litter.

All blood samples were collected in the morning or early afternoon.

After parturition, data on the delivery (natural or cesarean section), the number and weight of puppies (alive and stillborn), and survival after three weeks were documented.

Blood samples were collected by venipuncture from either the cephalic or the saphenous vein into plastic tubes (Sarstedt Tube 4.5 mL, Clotting Activator/Serum, 75 × 13 mm, Sarstedt AG & Co KG, Nümbrecht, Germany). Samples were left at room temperature for 30 to 60 min for clotting and then centrifuged at 5000 rpm or 2884 g for 5 min (Hettich Centrifuge EBA 20, Hettich, Tuttlingen, Germany). Serum was transferred into a serum tube (Simport Cryovial sterile with lip seal design, external threads, 2 mL Tubes, Boloeil QC, Canada), which was placed in a refrigerator at– 80°C until shipment. The storage temperature was checked daily, and variations of the measured temperature remained between -80°C and– 83°C. Storage duration at– 80°C of the samples ranged from 11 to 30 months.

Only complete sample sets with sufficient serum and no haemolytic appearance were submitted for Nuclear magnetic resonance (NMR) analyses.

For shipment preparation, the tubes were thawed for one to three hours, and then an amount of 0.3ml was transferred into a second serum tube (Simport Cryovial sterile with lip seal design, external threads, 2 mL tubes, Boloeil QC, Canada), both aliquots were again immediately frozen at– 80°C. Overnight shipment to PetBiomics, Finland, was performed in a Styrofoam box with plenty of dry ice.

Nuclear magnetic resonance (NMR) metabolomics analyses

A validated and highly automated canine-specific NMR metabolomics technology was utilized for metabolomics analyses of the collected serum samples [14]. The method quantitates 123 measurands from various molecular groups, including a comprehensive lipoprotein analysis, fatty acids, triglycerides, cholesterols, amino acids, glycolysis- and fluid balance-related metabolites, and a novel inflammatory marker glycoprotein acetyls (GlycA) [14]. A similar method has been largely utilized in human metabolomics studies [1719], including a study on the metabolic effects of human pregnancy [2]. Technical details of the method are provided elsewhere [1719].

Statistical analysis

All statistical analyses were performed using R version 4.1.3 (R Foundation for Statistical Computing, Vienna). First, the data were checked for missing observations. The data did not include any metabolite values missing at random. Values below the detection limit were treated as zero values in the following statistical analyses.

For metabolite selection, a Friedman-Test (a non-parametric alternative to a repeated-measures ANOVA) was used to determine which metabolite concentrations showed significant changes between the different time points and thus are affected by the course of the pregnancy. The Friedman-Test allows taking into account the repeated measures of each animal (6 time points per animal), the corresponding null hypothesis is that there are no changes in metabolite levels within each animal over the course of the pregnancy. Based on the observed data, the normality assumption could not be reliably checked for every of the 123 parameters. Therefore, a non-parametric approach was chosen for its higher robustness. All p-values were corrected for multiple comparisons using the Benjamini-Hochberg method, and the p-value cutoff for adjusted p-values was set at p<0.05.

Since p-values have limited interpretation for ‘omics data, where the number of observations is much smaller than the number of variables (27 animals << 123 metabolites), we used k-means Clustering for dimensionality reduction [19]. k-means Clustering was done using the z-scaled values of each metabolite. The optimal number of clusters was determined using the “gap” statistic (R package “cluster” version 2.1.3, [20]). Cluster were afterward modified based on the biochemical relationships between the metabolites (super/subcategories, absolute/relative values of the same metabolite), effectively creating 5 clusters from 123 variables. We assume that similar changes in the metabolites, defined by the clusters, are due to shared or related biological processes. To visualize the effect of the time points on the metabolites, “locally estimated scatterplot smoothing” (LOESS) was used. The reference intervals of the analysis [9] were added to the plots to provide reference on the typical concentrations of the metabolites and to highlight the magnitude of the change.

Results

The 27 dogs enrolled in the study (Table 1) belonged to 21 different breeds and had a median body weight of 22.8 kg (Min: 9.0, Q1: 15.1, Q3: 32.6, Max: 56.4kg). The median age was 4.35 years (Min 1.98, Q1: 2.9, Q3: 5.77, Max 8.1 years).

Fig 1 shows the metabolic parameters which were high in mid-pregnancy (P2). Metabolites which showed different patterns, i. e. low in mid-pregnancy, high in late pregnancy, high in lactation, and low in lactation are presented in Fig 2 (cluster 2, 3,4,5).

Fig 1. Metabolic parameters high in mid-pregnancy (Cluster 1).

Fig 1

Change in metabolic parameters over the course of canine pregnancy (E = estrus, P1-3 = early/mid/late pregnancy, L = lactation, A = after weaning). Points show the individual measurements. The solid line shows the change in average metabolite levels (LOESS). Dashed lines show the upper and lower limits of the metabolite reference intervals [9]. The p-values were calculated using a Friedman-Test with Benjamini-Hochberg correction. The p-value cutoff for adjusted p-values was p< 0.05.

Fig 2. Metabolic parameters low in mid-pregnancy, high in late pregnancy, high in lactation, and low in lactation (Cluster 2,3,4,5).

Fig 2

Change in metabolic parameters over the course of canine pregnancy (E = estrus, P1-3 = early/mid/late pregnancy, L = lactation, A = after weaning). Points show the individual measurements. The solid line shows the change in average metabolite levels (LOESS). Dashed lines show the upper and lower limits of the metabolite reference intervals [9]. The p-values were calculated using a Friedman-Test with Benjamini-Hochberg correction. The p-value cutoff for adjusted p-values was p< 0.05.

Discussion

Metabolism during pregnancy and lactation is a dynamic and precisely programmed process [8], as this stage of life is defined by rapid fetal or neonatal growth and development [2, 21]. Metabolite adaptations, such as increased hepatic glucose output, decreased peripheral insulin sensitivity, unchanged hepatic insulin sensitivity and lower peripheral insulin levels, allow the dam to maintain euglycemia during pregnancy [7, 22] and to support fetal growth despite the increasing nutritional demands [7]. Nevertheless, nutrition should be adapted to the respective pregnancy phase to ensure the health of the dam and the puppies [6]. It has been shown that protein deposition in maternal and fetal tissues increases throughout pregnancy, most occurring during the third trimester [21]. Furthermore, leptin increased proportionally with increased food intake during pregnancy, although an apparent body weight gain was observed only at day 60 [23]. The concentrations of metabolites in the blood serum of the bitch affect the corresponding concentrations and the composition of amniotic and allantoic fluid [7]. These fluids are essential during pregnancy, providing metabolites, protection, and the environment for normal fetal development [24].

Five distinct clusters were observed in the analysis of the patterns of the assessed parameters. The identified clusters were: parameters high (Cluster 1/Fig 1)/low (Cluster 2/Fig 2) in mid-pregnancy, parameters high at late pregnancy (Cluster 3/Fig 2), and parameters high (Cluster 4/Fig 2)/low (Cluster 5/Fig 2) in lactation. The clustering was based on similar patterns in metabolite concentrations with elevations and decreases in metabolite concentration occurring during similar time points within each cluster.

Cluster 1: Parameters high in mid-pregnancy

Total fatty acids tended to be higher during pregnancy than at other time points, albeit the differences were not significant. However, an increase in the molar concentration of individual fatty acids was also observed, which may explain changes in the total fatty acids. In addition, elevated total fatty acids have also been observed in another study on dogs [5] and in human pregnancies because a high concentration of fatty acids is necessary to meet the demands of fetuses [3]. Fatty acids play an important role in the development of the fetus and may also be involved in modulatory effects on the mother’s immune system [25]. It is well known that omega 3 fatty acids have anti-inflammatory effects [26] and it has been shown that some that fatty acids such as DHA can increase so called resolvins, which act inflammation resolving and anti-inflammatory [27]. Another strong link between metabolism and the immune system is the fatty acid composition of membranes of immune cells affects phagocytosis capabilities, T cell signaling and antigen presentation capability [28].

The concentration of free cholesterol (significant) was highest in mid-pregnancy. The same pattern was mirrored in total cholesterol and esterified cholesterol (both not significant). These findings are not following another study assessing 12 dogs assigned to four different diet groups in which plasma total cholesterol concentrations were depressed in early gestation and then increased in the later stages independently of the diet [29]. These differences refer mostly to a sample taken on day 42. At this time point, we did not sample the dogs. In another study no changes were found [5]. However, samples were taken at various and not exactly specified time points in pregnancy. It is well known that cholesterol also increases during human pregnancies [30].

Lipoproteins are divided into four major classes: chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL), with HDL being the most abundant lipoprotein in dogs [31]. Chylomicrons and VLDL are the main carriers of serum triglycerides, while HDL and LDL contain mainly cholesterol [32].

Our results show that the lipoprotein parameters show different patterns in the course of pregnancy and lactation in the dog. While the concentration of HDL particles (HDL-P) and VLDL particles (VLDL-P) show no changes, many others, such as HDL size, total lipids in very large HDL (XL-HDL total lipids), the concentration of LDL particles (LDL particles), LDL cholesterol, total lipids in LDL (LDL total lipids) peak in mid-pregnancy and decline after that. Other lipoprotein parameters peak in late pregnancy (see cluster 3). An increase of lipoprotein concentrations during canine pregnancy has also been shown in other studies [29]. It is well known that dogs have a unique lipid metabolism and produce substantial, cholesterol-rich HDL particles in hypercholesterolemia. Other than in dogs, in humans, these cholesterols are usually transformed into the more atherogenic LDL particles, which is believed to increase the risk of atherosclerosis in humans [32].

The percentage of polyunsaturated fatty acids (PUFA %) (significant) and PUFA (not significant) were high in mid-pregnancy. The same phenomenon has been shown in humans [3, 25]. In humans, polyunsaturated fatty acids (PUFA) accumulate in maternal fat depots in early pregnancy and become available for placental transfer during late pregnancy when the fetal growth rate is maximal and fetal requirements for PUFAs are greatly enhanced [33]. A high demand for PUFAs has also been shown in dogs [13].

Omega-3 unsaturated fatty acids and omega-3% were high in mid-pregnancy (both significant), as well as omega-6 (not significant) and omega-6% (significant). Omega-3 and Omega-6 PUFA are needed to ensure the physiologic development of nervous tissue, retinal tissue, kidney, liver, and skin functions [29].

Docosahexaenoic acid (DHA) belongs to Omega-3 fatty acids and was significantly elevated in mid-pregnancy, as well as DHA%. It plays a significant role during pregnancy and lactation because it contributes to brain development, accounting for over 10% of brain fatty acids [34]. DHA increases during gestation in humans, but its proportion of total lipids decreases [35]. The authors suggest that this indicates a preferential transfer of DHA across the placenta to the fetus [35].

Arachidonic acid (AA), an Omega-6 fatty acid, and AA% were significantly elevated in mid-pregnancy. At the same time, linoleic acid (LA), also an Omega-3 fatty acid and precursor for DHA and AA, was only slightly elevated in dogs. Concentrations of LA and AA also increase in pregnant women [35].

Total saturated fatty acids (SFA), including palmitic acid (PalA) and stearic acid (SteA), were slightly elevated during pregnancy in dogs. In humans, the increase of SFA and PalA is markedly higher until the third trimester [25].

Glycoprotein acetyls (GlycA) is a novel spectroscopic marker of systemic inflammation combining the N-acetyl methyl group proton signals of several acute-phase proteins. It peaks significantly in mid-pregnancy in dogs, which is in accordance with other recent findings [5]. In humans, the intra-individual biological variation of this marker is low, and the main acute-phase protein contributors to its signal are α1-acid glycoprotein, haptoglobin, α1-antitrypsin, and α1-antichymotrypsin [36]. It has been shown that GlycA is higher in pregnant women than in non-pregnant women [3]. The placentation process might explain the rise of this parameter and peak during mid-pregnancy. It is well known that acute phase proteins such as fibrinogen and c-reactive protein increase in the second half of pregnancy [37, 38]. A rise of acute phase proteins during pregnancy has also been shown in 12 pregnant bitches [39].

These findings follow the research on eight pregnant Beagle dogs, which has shown that Alpha-1-acid glycoprotein, which contributes to the GlycA signal, rises during dog pregnancy and peaks at around 45 days of gestation” [40]. In humans, Alpha-1-antitrypsin, another contributor to the GlycA signal, increases in pregnancy [41].

The only amino acid which shows a marked peak during mid-pregnancy is phenylalanine. In humans, it has been demonstrated that phenylalanine, alanine, and histidine were increased in pregnant women [3]. In dogs, alanine and histidine seem not to increase during pregnancy. Phenylalanine is required for protein synthesis and is intracellularly converted to tyrosine, which, in turn, is either used for protein synthesis, oxidized, or converted to the important neurotransmitters epinephrine, norepinephrine, and dopamine [42]. It has been shown that excessive feeding of phenylalanine to rats impairs proliferation and hypertrophy in the brain of their fetuses [43], but the dietary requirement for phenylalanine in healthy human pregnancies or canine pregnancies has not been determined yet. Dietary phenylalanine requirements seem not to vary between adult and non-pregnant dog breeds [44].

Cluster 2: Parameters low in mid-pregnancy

Oleic acid is a monounsaturated omega-9 fatty acid. Compared to other unsaturated fatty acids (see Cluster 1), its concentration slightly declines in mid-pregnancy. In humans, Oleic acid increases during pregnancy [25].

Free cholesterol and phospholipids in large VLDL (L-VLDL) and total lipids in extensive VLDL (XL-VLDL total lipids) decline significantly during mid-pregnancy and increase towards the end of pregnancy. An increase in all parameters during pregnancy has been observed in humans [45].

Cluster 3: Parameters high in late pregnancy

Through various mechanisms, pregnancy causes insulin resistance, suppressing the intracellular transport of glucose and increasing blood glucose concentrations in dogs [4, 46, 47]. Glucose concentrations significantly increase during late pregnancy and remain high until the time after weaning. Despite the pronounced insulin resistance in pregnant compared with non-pregnant diestrous bitches [38], gestational diabetes mellitus in dogs is rare [48]. The same mechanisms of insulin resistance have been described in humans [49, 50], albeit several groups have found lower glucose concentrations in pregnant women compared with non-pregnant ones [3]. The mechanism causing this decline is not well understood. Potential contributing factors include dilutional effects, an increased utilization by the fetoplacental unit or increased maternal uptake secondary to increased β-cell function, and/or inadequate hepatic production [50].

Total triglycerides, LDL Triglycerides, and VLDL triglycerides significantly peak in late pregnancy. This is in accordance with findings in normal human pregnancies. Shen et al. [51] found that the levels of lipids, including TG, TC, and LDL cholesterol, increased gradually during gestation and peaked before delivery; meanwhile, HDL cholesterol amounts increased from the 1st to 2nd trimester with a slight decrease in the 3rd trimester. Furthermore, in human pregnancies, an abnormal increase in triglycerides during pregnancy is associated with gestational diabetes mellitus [51]. The possible disease correlations of abnormally high triglycerides during canine pregnancy require further study. Similar to gestational diabetes mellitus, hypertensive disorders are not common complications of canine pregnancy. Interestingly, unlike humans, dogs’ HDL triglycerides are not affected by pregnancy or lactation.

Cluster 4: Parameters high in lactation

It has been shown that lactate and pyruvate are more elevated in pregnant women than in non-pregnant women [3]. The lactate, pyruvate, and acetate concentrations significantly rise towards late pregnancy and lactation, presumably reflecting the higher demands of energy metabolism, even if their medians remain within the reference intervals at all time points. Whether lactate can be used as an indicator for sepsis or other pregnancy-related disorders in dogs as it is used in humans [52] requires further study since all bitches included in our study had undisturbed pregnancies.

The total concentration of branched-chain amino acids (BCAA), which includes leucine, isoleucine, and valine, shows a marked increase during lactation. Interestingly, isoleucine and valine show the same pattern, whereas leucine shows low concentrations during lactation (see cluster 5). The same is true for the amino acid glycine. Glutamine, glycine, valine, and tyrosine were lower in pregnant women compared with non-pregnant women; no differences were found for isoleucine and leucine between pregnant and non-pregnant women [3].

Creatinine shows a significant decrease in mid-pregnancy, which is in accordance with other findings in dogs [5] and in pregnant women. It has been stated that a physiologic increase in the glomerular filtration rate during pregnancy results in a decrease in the concentration of serum creatinine [53]. In addition, it has been shown that creatinine was lower in pregnant women compared to non-pregnant women [3].

Cluster 5: Parameters low in lactation

The observed significant decline of albumin during late pregnancy and lactation has also been well documented in dogs [5] and humans during and after normal pregnancies [3, 54]. It is believed that this decline is caused by physiologic hemodilution but may lead to physiological edema and even may associate with conditions such as eclampsia [54]. In addition, it has been shown that albumin concentrations increase in the allantoic fluid in late canine pregnancy [24].

Docosapentaenoic acid (DPA) is also significantly elevated during pregnancy but shows a significant decline during lactation, which is also visible using the parameter DPA%.

The concentration of the amino acid histidine remains stable at all time points, except for a significant decrease during lactation. Histidine likely plays a role in milk production, as it has been shown for cows, who have an increased energy-corrected milk yield when supplemented with histidine [55].

The amino acid leucine showed a significant increase in its concentration during early pregnancy and a decline during mid and late pregnancy and lactation. This contrasts with other branched-chain amino acids (see cluster 4). This decline is likely connected with milk production since leucine plays a vital role in milk production, as shown in cows [56].

Limitations of the study

The metabolome is affected by several internal factors such as gene and protein activity and external factors, including diet and environmental factors [15]. In our study, privately owned dogs were used, which were housed and fed under different conditions. Furthermore, 21 breeds and dogs aged between 2 and 8 years were included. To what extent these heterogeneous conditions may have affected the results remains open. However, the included dogs may better reflect the real-life heterogeneity seen in pregnant dogs than laboratory animals. Experienced breeders kept most dogs so that appropriate housing and feeding under consideration of the reproductive status of the female dog is likely.

A further limitation is that dogs did not fast before sampling because this would not have been acceptable for pregnant and lactating dogs. The timing of collection of the blood samples also showed a mild variation of a few hours; therefore, the impact of diurnal influence cannot be excluded. However, as they were usually sampled in the morning, diurnal variance would be expected to be small. Another potential limitation is the small number of dogs originating from one geographical area.

Some comparisons of our findings with findings from human pregnancies need to be interpreted with caution. Pregnancy of dogs is around 63 days, significantly shorter, and the offspring usually is much larger. Puppies are born physiologically immature and dependent on their mother´s care and milk supply [57]. In the study, the dogs delivered between 1 and 12 puppies.

In addition, research on pregnant dogs has led to several contradictory findings, which makes interpretation of actual metabolic and hematologic findings difficult [1]. For example, it was described more than 40 years ago that some bitches develop progressive, normochromic, and normocytic anemia beginning in mid-pregnancy [9]. While some authors consider this normal, other groups suggest that haematocrits should remain in the normal reference range and that bitches with anaemia should be examined for other concurrent diseases [58].

The samples for this study were taken throughout the year. However, previous research using the same method has shown that only minimal seasonal variation exists in the vast majority of metabolites [59]. Therefore, the season was not taken into account during the data analysis.

In our current study, samples were stored at −80°C for up to 30 months before analysis. In a previous study validating the NMR platform, all studied metabolites were stable at −80°C for at least 12 months [14]. However, the impact of more extended storage on canine samples is lacking.

In many species, it can be challenging to determine whether changes detected during pregnancy are related to the presence of a conceptus or the increased progesterone concentrations [39].

Conclusions

Several metabolites such as albumin, GlycA, fatty acids, lipoproteins, glucose, and some amino acids show similar patterns during canine pregnancy and lactation as shown in humans. The patterns of some other parameters, such as branched-chain amino acids, alanine and histidine, seem to differ.

To date, it is unclear for most metabolites if observed changes arise from modified resorption from the intestines, modified production or metabolism in the maternal tissues, or their migration through the placenta. In addition, it has hardly been investigated so far to what degree fetal fluid concentrations of specific metabolites are influenced by maternal concentrations [7]. Hence, further species-specific research is needed to shed more light on these questions.

Understanding the molecular changes during pregnancy and the relation to discrete biological events such as embryo development and placentation may support understanding of these processes, learn more about causes of infertility or diseases, and aid in identifying treatments for these conditions [59]. It is essential to understand physiological changes during pregnancy and lactation so that these changes are not misinterpreted as indicators of disease or malnutrition. Furthermore, knowledge of the physiological changes is important for designing studies on metabolites to adjust inclusion criteria, i. e. if or not to include also pregnant or lactating bitches, and for interpreting the results.

Further research should provide molecular reference ranges in normal pregnancies in relation to studies of adverse pregnancy outcomes [3]. In that regard, metabolomics findings may help monitor vital functions of pre-, intra-, and post-partum bitches and early detection of illness [1].

Supporting information

S1 File. Metabolomics raw data.

(CSV)

Acknowledgments

The authors wish to thank the participating breeders for their cooperation and interest in the study.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The costs were covered by the Freie Universitaet Berlin (examination, sampling) without any specific funding and PetBiomics Ltd provided material support (Analyses). PetBiomics Ltd employee Claudia Ottka and PetBiomics Ltd chairman Hannes Lohi were involved in the analysis and the preparation of the manuscript. The funders had no role in study design, data collection and decision to publish.

References

  • 1.Arlt SP. The bitch around parturition. Theriogenology. 2020; 150:452–7. Epub 2020/03/04. doi: 10.1016/j.theriogenology.2020.02.046 . [DOI] [PubMed] [Google Scholar]
  • 2.Cardinali L, Troisi A, Verstegen JP, Menchetti L, Elad Ngonput A, Boiti C, et al. Serum concentration dynamic of energy homeostasis hormones, leptin, insulin, thyroid hormones, and cortisol throughout canine pregnancy and lactation. Theriogenology. 2017; 97:154–8. Epub 2017/04/28. doi: 10.1016/j.theriogenology.2017.04.040 . [DOI] [PubMed] [Google Scholar]
  • 3.Wang Q, Würtz P, Auro K, Mäkinen V-P, Kangas AJ, Soininen P, et al. Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. BMC Med. 2016; 14:205. Epub 2016/12/13. doi: 10.1186/s12916-016-0733-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Johnson CA. Glucose homeostasis during canine pregnancy: Insulin resistance, ketosis, and hypoglycemia. Theriogenology. 2008; 70:1418–23. Epub 2008/09/27. doi: 10.1016/j.theriogenology.2008.09.008 . [DOI] [PubMed] [Google Scholar]
  • 5.Ottka C, Vapalahti K, Arlt SP, Bartel A, Lohi H. The metabolic differences of anestrus, heat, pregnancy, pseudopregnancy, and lactation in 800 female dogs. Front Vet Sci. 2023; 10:1105113. Epub 2023/02/02. doi: 10.3389/fvets.2023.1105113 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Greco DS. Nutritional supplements for pregnant and lactating bitches. Theriogenology. 2008; 70:393–6. Epub 2008/06/12. doi: 10.1016/j.theriogenology.2008.04.013 . [DOI] [PubMed] [Google Scholar]
  • 7.Balogh O, Bruckmaier R, Keller S, Reichler IM. Effect of maternal metabolism on fetal supply: Glucose, non-esterified fatty acids and beta-hydroxybutyrate concentrations in canine maternal serum and fetal fluids at term pregnancy. Anim Reprod Sci. 2018; 193:209–16. Epub 2018/04/20. doi: 10.1016/j.anireprosci.2018.04.072 . [DOI] [PubMed] [Google Scholar]
  • 8.Liang L, Rasmussen M-LH, Piening B, Shen X, Chen S, Röst H, et al. Metabolic Dynamics and Prediction of Gestational Age and Time to Delivery in Pregnant Women. Cell. 2020; 181:1680–1692.e15. doi: 10.1016/j.cell.2020.05.002 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Concannon PW, Powers ME, Holder W, Hansel W. Pregnancy and parturition in the bitch. Biol Reprod. 1977; 16:517–26. [PubMed] [Google Scholar]
  • 10.Lúcio CF, Silva LCG, Rodrigues JA, Veiga GAL, Vannucchi CI. Peripartum Haemodynamic Status of Bitches with Normal Birth or Dystocia // Peripartum haemodynamic status of bitches with normal birth or dystocia. Reprod Dom Anim. 2009; 44 // 44 Suppl 2:133–6. doi: 10.1111/j.1439-0531.2009.01427.x . [DOI] [PubMed] [Google Scholar]
  • 11.Schulze LS-C, Heuwieser W, Arlt SP. Body temperature of bitches in the first week after parturition measured by ingestible loggers. Reprod Domest Anim. 2018; 53 Suppl 3:63–9. doi: 10.1111/rda.13330 . [DOI] [PubMed] [Google Scholar]
  • 12.Yang J, Chang Q, Dang S, Liu X, Zeng L, Yan H. Dietary Quality during Pregnancy and Congenital Heart Defects. Nutrients. 2022; 14. Epub 2022/09/04. doi: 10.3390/nu14173654 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Heinemann KM, Waldron MK, Bigley KE, Lees GE, Bauer JE. Long-chain (n-3) polyunsaturated fatty acids are more efficient than alpha-linolenic acid in improving electroretinogram responses of puppies exposed during gestation, lactation, and weaning. J Nutr. 2005; 135:1960–6. doi: 10.1093/jn/135.8.1960 . [DOI] [PubMed] [Google Scholar]
  • 14.Ottka C, Vapalahti K, Puurunen J, Vahtera L, Lohi H. A novel canine nuclear magnetic resonance spectroscopy-based metabolomics platform: Validation and sample handling. Vet Clin Pathol. 2021; 50:410–26. Epub 2021/08/24. doi: 10.1111/vcp.12954 . [DOI] [PubMed] [Google Scholar]
  • 15.Puurunen J, Ottka C, Salonen M, Niskanen JE, Lohi H. Age, breed, sex and diet influence serum metabolite profiles of 2000 pet dogs. R Soc Open Sci. 2022; 9:211642. Epub 2022/02/16. doi: 10.1098/rsos.211642 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hinderer J, Lüdeke J, Riege L, Haimerl P, Bartel A, Kohn B, et al. Progesterone Concentrations during Canine Pregnancy. Animals (Basel). 2021; 11. Epub 2021/11/24. doi: 10.3390/ani11123369 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Soininen P, Kangas AJ, Würtz P, Tukiainen T, Tynkkynen T, Laatikainen R, et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 2009; 134:1781–5. Epub 2009/07/30. doi: 10.1039/b910205a . [DOI] [PubMed] [Google Scholar]
  • 18.Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015; 8:192–206. doi: 10.1161/CIRCGENETICS.114.000216 . [DOI] [PubMed] [Google Scholar]
  • 19.Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies. Am J Epidemiol. 2017; 186:1084–96. doi: 10.1093/aje/kwx016 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K. cluster: Cluster Analysis Basics and Extensions.; 2022. [Google Scholar]
  • 21.Elango R, Ball RO. Protein and Amino Acid Requirements during Pregnancy. Adv Nutr. 2016; 7:839S–44S. Epub 2016/07/15. doi: 10.3945/an.115.011817 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Connolly CC, Papa T, Smith MS, Lacy DB, Williams PE, Moore MC. Hepatic and muscle insulin action during late pregnancy in the dog. Am J Physiol Regul Integr Comp Physiol. 2007; 292:R447–52. Epub 2006/09/14. doi: 10.1152/ajpregu.00385.2006 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Troisi A, Cardinali L, Menchetti L, Speranza R, Verstegen JP, Polisca A. Serum concentrations of leptin in pregnant and non-pregnant bitches. Reprod Domest Anim. 2020; 55:454–9. Epub 2020/02/20. doi: 10.1111/rda.13637 . [DOI] [PubMed] [Google Scholar]
  • 24.Tal S, Sutton GA, Arlt SP, Bar-Gal GK. Analysis of biochemical parameters in canine fetal fluids during the second half of pregnancy. Theriogenology. 2022; 189:31–41. Epub 2022/05/20. doi: 10.1016/j.theriogenology.2022.05.009 . [DOI] [PubMed] [Google Scholar]
  • 25.Aparicio E, Martín-Grau C, Hernández-Martinez C, Voltas N, Canals J, Arija V, et al. Changes in fatty acid levels (saturated, monounsaturated and polyunsaturated) during pregnancy. BMC Pregnancy Childbirth. 2021; 21:778. Epub 2021/11/17. doi: 10.1186/s12884-021-04251-0 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Alvarez-Curto E, Milligan G. Metabolism meets immunity: The role of free fatty acid receptors in the immune system. Biochem Pharmacol. 2016; 114:3–13. Epub 2016/03/19. doi: 10.1016/j.bcp.2016.03.017 . [DOI] [PubMed] [Google Scholar]
  • 27.Fritsche K. Fatty acids as modulators of the immune response. Annu Rev Nutr. 2006; 26:45–73. doi: 10.1146/annurev.nutr.25.050304.092610 . [DOI] [PubMed] [Google Scholar]
  • 28.Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids. 2008; 79:101–8. Epub 2008/10/23. doi: 10.1016/j.plefa.2008.09.016 . [DOI] [PubMed] [Google Scholar]
  • 29.Wright-Rodgers AS, Waldron MK, Bigley KE, Lees GE, Bauer JE. Dietary fatty acids alter plasma lipids and lipoprotein distributions in dogs during gestation, lactation, and the perinatal period. J Nutr. 2005; 135:2230–5. doi: 10.1093/jn/135.9.2230 . [DOI] [PubMed] [Google Scholar]
  • 30.Bartels Ä, O’Donoghue K. Cholesterol in pregnancy: a review of knowns and unknowns. Obstet Med. 2011; 4:147–51. Epub 2011/07/28. doi: 10.1258/om.2011.110003 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Maldonado EN, Romero JR, Ochoa B, Aveldaño MI. Lipid and fatty acid composition of canine lipoproteins. Comp Biochem Physiol B Biochem Mol Biol. 2001; 128:719–29. doi: 10.1016/s1096-4959(00)00366-3 . [DOI] [PubMed] [Google Scholar]
  • 32.Xenoulis PG, Steiner JM. Lipid metabolism and hyperlipidemia in dogs. Vet J. 2010; 183:12–21. Epub 2009/01/23. doi: 10.1016/j.tvjl.2008.10.011 . [DOI] [PubMed] [Google Scholar]
  • 33.Herrera E, Amusquivar E, López-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res. 2006; 65 Suppl 3:59–64. Epub 2006/04/10. doi: 10.1159/000091507 . [DOI] [PubMed] [Google Scholar]
  • 34.Innis SM. Impact of maternal diet on human milk composition and neurological development of infants. Am J Clin Nutr. 2014; 99:734S–41S. Epub 2014/02/05. doi: 10.3945/ajcn.113.072595 . [DOI] [PubMed] [Google Scholar]
  • 35.Wilson NA, Mantzioris E, Middleton PT, Muhlhausler BS. Gestational age and maternal status of DHA and other polyunsaturated fatty acids in pregnancy: A systematic review. Prostaglandins Leukot Essent Fatty Acids. 2019; 144:16–31. Epub 2019/04/18. doi: 10.1016/j.plefa.2019.04.006 . [DOI] [PubMed] [Google Scholar]
  • 36.Connelly MA, Otvos JD, Shalaurova I, Playford MP, Mehta NN. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J Transl Med. 2017; 15:219. Epub 2017/10/27. doi: 10.1186/s12967-017-1321-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ulutas PA, Musal B, Kiral F, Bildik A. Acute phase protein levels in pregnancy and oestrus cycle in bitches. Res Vet Sci. 2009; 86:373–6. Epub 2008/11/07. doi: 10.1016/j.rvsc.2008.09.001 . [DOI] [PubMed] [Google Scholar]
  • 38.Concannon PW, McCann JP, Temple M. Biology and endocrinology of ovulation, pregnancy and parturition in the dog. J Reprod Fertil Suppl. 1989; 39:3–25. [PubMed] [Google Scholar]
  • 39.Holst BS, Gustavsson MH, Johannisson A, Hillström A, Strage E, Olsson U, et al. Inflammatory changes during canine pregnancy. Theriogenology. 2019; 125:285–92. Epub 2018/11/15. doi: 10.1016/j.theriogenology.2018.11.016 . [DOI] [PubMed] [Google Scholar]
  • 40.Kuribayashi T, Shimizu M, Shimada T, Honjyo T, Yamamoto Y, Kuba K, et al. Alpha 1-acid glycoprotein (AAG) levels in healthy and pregnant beagle dogs. Exp Anim. 2003; 52:377–81. doi: 10.1538/expanim.52.377 . [DOI] [PubMed] [Google Scholar]
  • 41.Lisowska-Myjak B, Sygitowicz G, Wolf B, Pachecka J. Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001; 99:53–6. doi: 10.1016/s0301-2115(01)00356-6 . [DOI] [PubMed] [Google Scholar]
  • 42.Ennis MA, Rasmussen BF, Lim K, Ball RO, Pencharz PB, Courtney-Martin G, et al. Dietary phenylalanine requirements during early and late gestation in healthy pregnant women. Am J Clin Nutr. 2020; 111:351–9. doi: 10.1093/ajcn/nqz288 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Manabe S, Inui K, Uenishi K. Effect of excess phenylalanine diet during pregnancy on fetal brain growth in rats. Tokushima J Exp Med. 1993; 40:125–35. [PubMed] [Google Scholar]
  • 44.Mansilla WD, Gorman A, Fortener L, Shoveller AK, Mansilla WD, Gorman A, et al. Dietary phenylalanine requirements are similar in small, medium, and large breed adult dogs using the direct amino acid oxidation technique. // Dietary phenylalanine requirements are similar in small, medium, and large breed adult dogs using the direct amino acid oxidation technique. J Anim Sci. 2018; 96:3112–20. doi: 10.1093/jas/sky208 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Knopp RH, Warth MR, Charles D, Childs M, Li JR, Mabuchi H, et al. Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. Biol Neonate. 1986; 50:297–317. doi: 10.1159/000242614 . [DOI] [PubMed] [Google Scholar]
  • 46.Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. J Am Anim Hosp Assoc. 2018; 54:1–21. doi: 10.5326/JAAHA-MS-6822 . [DOI] [PubMed] [Google Scholar]
  • 47.Wada T, Hori S, Sugiyama M, Fujisawa E, Nakano T, Tsuneki H, et al. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2010; 298:E881–8. Epub 2010/01/13. doi: 10.1152/ajpendo.00649.2009 . [DOI] [PubMed] [Google Scholar]
  • 48.Armenise A, Pastorelli G, Palmisano A, Sontas HB, Romagnoli S, Armenise A, et al. Gestational Diabetes Mellitus with Diabetic Ketoacidosis in a Yorkshire Terrier Bitch // Gestational diabetes mellitus with diabetic ketoacidosis in a Yorkshire terrier bitch. J Am Anim Hosp Assoc. 2011; 47:285–9. Epub 2011/06/14. doi: 10.5326/Jaaha-Ms-5668 . [DOI] [PubMed] [Google Scholar]
  • 49.Meo SA, Hassain A. Metabolic Physiology in Pregnancy. J Pak Med Assoc. 2016; 66:S8–S10. [PubMed] [Google Scholar]
  • 50.Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007; 50:938–48. doi: 10.1097/GRF.0b013e31815a5494 . [DOI] [PubMed] [Google Scholar]
  • 51.Shen H, Liu X, Chen Y, He B, Cheng W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ Open. 2016; 6:e013509. Epub 2016/12/23. doi: 10.1136/bmjopen-2016-013509 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Albright CM, Ali TN, Lopes V, Rouse DJ, Anderson BL. Lactic acid measurement to identify risk of morbidity from sepsis in pregnancy. Am J Perinatol. 2015; 32:481–6. Epub 2014/12/08. doi: 10.1055/s-0034-1395477 . [DOI] [PubMed] [Google Scholar]
  • 53.Maynard SE, Thadhani R. Pregnancy and the kidney. J Am Soc Nephrol. 2009; 20:14–22. Epub 2008/12/31. doi: 10.1681/ASN.2008050493 . [DOI] [PubMed] [Google Scholar]
  • 54.Sufrin S, Nessa A, Islam MT, Das RK, Rahman MH. Study on Serum Albumin in Third Trimester of Pregnancy. Mymensingh Med J. 2015; 24:464–6. [PubMed] [Google Scholar]
  • 55.Räisänen SE, Lage CFA, Oh J, Melgar A, Nedelkov K, Chen X, et al. Histidine dose-response effects on lactational performance and plasma amino acid concentrations in lactating dairy cows: 1. Metabolizable protein-adequate diet. J Dairy Sci. 2021; 104:9902–16. Epub 2021/06/05. doi: 10.3168/jds.2021-20188 . [DOI] [PubMed] [Google Scholar]
  • 56.Bequette BJ, Metcalf JA, Wray-Cahen D, Backwell FR, Sutton JD, Lomax MA, et al. Leucine and protein metabolism in the lactating dairy cow mammary gland: responses to supplemental dietary crude protein intake. J Dairy Res. 1996; 63:209–22. doi: 10.1017/s002202990003171x . [DOI] [PubMed] [Google Scholar]
  • 57.Tønnessen R, Borge KS, Nødtvedt A, Indrebø A. Canine perinatal mortality: a cohort study of 224 breeds. Theriogenology. 2012; 77:1788–801. Epub 2012/02/25. doi: 10.1016/j.theriogenology.2011.12.023 . [DOI] [PubMed] [Google Scholar]
  • 58.de Cramer KGM, Joubert KE, Nöthling JO. Hematocrit changes in healthy periparturient bitches that underwent elective cesarean section. Theriogenology. 2016; 86:1333–40. Epub 2016/05/04. doi: 10.1016/j.theriogenology.2016.04.075 . [DOI] [PubMed] [Google Scholar]
  • 59.Burnum-Johnson KE, Baker ES, Metz TO. Characterizing the lipid and metabolite changes associated with placental function and pregnancy complications using ion mobility spectrometry-mass spectrometry and mass spectrometry imaging. Placenta. 2017; 60 Suppl 1:S67–S72. Epub 2017/03/29. doi: 10.1016/j.placenta.2017.03.016 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mükremin Ölmez

1 Feb 2023

PONE-D-22-35093Metabolomics during canine pregnancy and lactationPLOS ONE

Dear Dr. Bartel,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mükremin Ölmez

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

https://helda.helsinki.fi/bitstream/handle/10138/335051/vcp.12954.pdf?isAllowed=y&sequence=1

https://academic.oup.com/ajcn/article/111/2/351/5638892?login=false

https://daneshyari.com/article/preview/8403911.pdf 

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

3. Thank you for stating the following financial disclosure: 

"The author(s) received no specific funding for this work. The costs were covered by the Freie Universitaet Berlin (examoination, sampling) and PetBiomics Ltd (Analyses)."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Competing Interests section: 

"I have read the journal's policy and the authors of this manuscript have the following competing interests: Claudia Ottka was an employee and Hannes Lohi is a shareholder and the chairman of the board of PetBIOMICS Ltd, who developed and provides the metabolomics test. All other authors declare to have no competing interests."

We note that you received funding from a commercial source: PetBIOMICS Ltd

Please provide an amended Competing Interests Statement that explicitly states this commercial funder, along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products, etc. 

Within this Competing Interests Statement, please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 

Please include your amended Competing Interests Statement within your cover letter. We will change the online submission form on your behalf.

Additional Editor Comments:

Dear Alexander Bartel,

Your manuscript has now been reviewed by experts in the field. Please find your manuscript with the referee reports in the attachments. Regards.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript (Metabolomics during canine pregnancy and lactation) by Alexander Bartel is interesting for the researchers and scientific community. Overall, this is a clear, concise, and well-written manuscript. Therefore, I must recommend this for publication after following minor revisions.

Reviewer #2: Dear authors,

Studies on the metabolic profile of dogs at various stages of pregnancy and lactation are very limited. For this reason, the study is original and contains very high quality data. But I recommend that you review the writing of almost all parts of the work.

Corrections to the manuscript are shown in the attached pdf file.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-22-35093_reviewer.pdf 4.pdf

Attachment

Submitted filename: PONE-D-22-35093. Corr.pdf

PLoS One. 2023 May 10;18(5):e0284570. doi: 10.1371/journal.pone.0284570.r002

Author response to Decision Letter 0


16 Mar 2023

Reviewer #1:

The manuscript (Metabolomics during canine pregnancy and lactation) by Alexander Bartel is interesting for the researchers and scientific community. Overall, this is a clear, concise, and well-written manuscript. Therefore, I must recommend this for publication after following minor revisions.

Page 1: choose Key words that are more relevant

AU: changed

Line 22-42: I suggest major re-write of the abstract including results in precise manner

AU: Abstract has been re-written. Thank you.

Line 44: Improve the Introduction part of the manuscript with little more background.

AU: Some more details on metabolism demands have been included (lines 52 – 58)

Line 68: In line 68 please replace and with ,

AU: Done

Line 73: You may replace word Dog with Bitch or Female Dog

AU: Replaced with female dog.

Line 77: in line 77 please correct some grammatical errors

AU: Corrected.

Line 80: Instead of word dogs use Bitch, it will be more appropriate

AU: Done

Line 88: please mention abbreviation "P" stand for

AU: Added

Line 108: In line 108 NMR stands for ? avoid use of abbreviation first time in the manuscript

AU: Nuclear magnetic resonance (NMR) added.

Line 110: in line 110 please add space

AU: We tried to find words or other parts of the text where an additional space is necessary. Sadly, we were not able to find any positions that we believed were meant by this comment. Please, could you indicate in more detail where you see the need of another space?

Line 389: Please update references

References:

Ellen Behrend,2018 some other latest references are available

AU: Reference has been added, thank you

Sebastian P.Arlt 2020 latest references are available.

AU: More recent references have been included

please check Jiaomei Yang 2022 reference

AU: Has been included in the introduction

Please use some latest reference. Concannon,1989

AU: Another and more recent reference has been added

There are more latest references available please update references. Lain, 2007

AU: A more recent reference has been added

Reviewer #2:

Dear authors, Studies on the metabolic profile of dogs at various stages of pregnancy and lactation are very limited. For this reason, the study is original and contains very high quality data. But I recommend that you review the writing of almost all parts of the work.

Line 23-31: Dear authors, Please revise the Abstract section. When I read the Abstract, I don't fully understand your study. So write briefly the material, method and results of your study. Please do not write "Introduction section" descriptions in this section.

AU: Thank you, we revised the abstract intensively

Line 46-48: Please, could you revise this sentence?

AU: revised

Line 52: ??? Which parameters?

AU: specified

Line 60: The main purpose of this study is actually this sentence. Therefore, please explain why some parameter changes are important in the relevant processes.

AU: We have revised the beginning of the introduction according to the suggestions by reviewer 1. We hope that in this context this sentence is more clear now (now line 78 ff).

Line 65: [9,10]

AU: fixed

Line 70: One of the most important factors affecting the metabolic profile is diet. There is no information about this in the material and method section. Dogs of different owners cannot be fed the same diet. How did you eliminate this?

AU: We have added a sentence in the materials and methods section (line 89). Thank you!

We agree that the heterogeneity of feeding plays an important role. Therefore, we discussed this (see limitations of the study). Feeding a standardized diet would have resulted in a very low compliance of the owners. Furthermore, we included dogs of 21 breeds, which is also a significant confounder. Since we tested every dog at six time points, we use every dog as its “own control”, which might significantly reduce the confounding effects of the different attributes.

Line 72: Using animals with similar characteristics in metabolic profile studies always provides more reliable results. Isn't this important to you? Why didn't you use dogs with similar characteristics in your study? The number of dogs you use and the characteristics of the dogs are not enough, so it means that more comprehensive studies should be done on this subject. If there is a need for other studies, why didn't you do such a more comprehensive study?

AU: We agree that studies under much more standardized conditions, e. g. in a uniform Beagle colony may provide much more homogeneity (internal validity). However, these studies do not reflect the heterogenous situations we see in veterinary practice. Furthermore, a uniform colony may suffer from unknown individual features which might limit the external validity of findings.

To reduce bias, we made sure that we really have samples from all six time points in the study so that no samples from different dogs at different time points were compared. This approach may still provide deep insights into the changes of metabolites since every dog served as its “own control”. We just assume, that the changes over the course of the pregnancy are similar between dogs (within animal) and not that dogs of different body weights have similar metabolite levels.

Line 72: What kind of diets were the dogs fed before pregnancy, during pregnancy and lactation? You should explain about it. The content of the diet may have been effective on serum metabolic profile markers. Please provide detailed information about it.

AU: As written above and thanks to your comments, we included a statement that all dogs were fed individual diets chosen by the owner. In general, based on common sense we advised to feed the normal diet the dog was used to during pregnancy. In the last third we suggested an increase of food supply to 120% (small litter) or up to 150% (large litter). Most breeders began to mix puppy food under the ration from around ten days before parturition (increasing proportions). After parturition the food supply was further increased until week 3 (up to 300% for dogs with very large litters). In all these cases the owners chose their favorite food for their dog and adjusted it to the stage and to the litter size.

Line 72-73: Age, parity, body weight and breed (perhaps) are effective on metabolic profile. How did you eliminate relevant factors in your study?

AU: Again, we agree that these are important factors. But since every dog can be seen as its “own control”, confounding effects are limited. From all dogs samples were taken at every time point.

Line 80: “80 Dogs were initially presented for ovulation timing.” Please explain.

AU: Thank you for pointing this out. This was a mistake and not the case in this study. We have deleted this information

Line 80: “After they met the inclusion criteria,” Which criteria?

AU: Inclusion criteria were given in line 84ff. We enrolled only dogs which were healthy, receiving no medication and becoming pregnant during the project.

Line 84: Isn't it a great shortcoming not to collect blood on delivery day?

AU: We agree that on day of delivery we might have revealed special metabolic effects because of uterine labor, onset of lactation and other phenomena. However, since we have used privately owned dogs this was not possible. Stress is a major cause for dystocia and we wanted to avoid any intervention that may have been negative in terms of a normal parturition, potentially leading to C-section. In addition, the owner’s compliance for blood samples during or shortly after delivery would have been poor.

Line 96: Did you include post-cesarean delivery cases in the study? Such cases are unacceptable. You identify physiological changes. Cesarean delivery cases can change your values.

AU: Thank you for this important remark. Indeed, three dogs underwent an emergency C-section (no planned/elective ones). All dogs did not have C-sections before the beginning of the study. All three dogs having C-sections in the course of this study recovered very fast so that we assume that the surgery did not affect the metabolomic features around three weeks after parturition (L). But we have now indicated the Cesareans in Table 1. We suggest keeping these animals.

Line 120: remove

AU: We suggest keeping this sentence in order to guide interested readers to more information about other uses of nuclear magnetic resonance metabolomics, since this method is not widely known yet.

Line 151: Can you add the averages of parameters such as body weight, age, parity at the bottom of the table? please.

AU: Have been added

Line 195: Can you add the studies on the change of fatty acids in dogs during pregnancy and lactation? Please include results from dog references alongside human references.

AU: reference has been added (line 217)

Line 196: Yes, I agree, but this sentence needs a little more clarification. Because if the relationship between fatty acids and immune functions is not explained in a few sentences, it creates confusion. Immune cell activation, relationship with T cells, antigen presentation etc.

AU: We have added two sentences to explain better the link between metabolism and the immune system (line 220 – 225)

Line 199: This is a good result. What might have caused this increase? Can you add a description?

AU: The reasons for the increase of cholesterol is not clear for us. Like you, we usually would have expected a later rise (if any) in the phases of higher energy demands.

Line 200: I think there is a tendency for total cholesterol to increased in late pregnancy. We can see the worst result of not having dogs under similar breeding conditions, age and weight in the lipid profile.

AU: all cholesterol parameters follow the same pattern with a peak in mid-pregnancy. We guess that future studies should use more sampling time points. Maybe the then found patterns and underlying reasons become more clear.

We suggest that - for the moment - we need to accept that we found this pattern in privately owned dogs which represent the “average” dog population better than a standardized dog colony. But we also agree that these thrilling findings need to be evaluated much more in future projects to learn more about influences such as age, weight etc.

Line 205: increases

AU: changed

Line 209: remove

AU: we suggest keeping this statement because it may help readers not familiar with lipoproteins to better understand the parameters (now line 237)

Line 210: In this study? Or is it the result of other studies?

AU: In this study, clarified. (now line 239)

Line 218: Can you revise this discussion text? There should be studies on dogs.

AU: Thank you. Two other studies are now referenced (line 244)

Line 221: https://academic.oup.com/jn/article/135/8/1960/4663933?login=false How does PUFA change in dogs?

AU: Added a sentence, that PUFA demand is also increased in pregnant dogs, citing the provided paper. Thank you! (line 254)

Line: 226: Should the serum concentration be increased if Omega-3 is needed to ensure the physiological development of nervous tissue, retinal tissue, kidney, liver and skin functions? Shouldn't the amount be reduced as it is used?

AU: These are very interesting questions which we believe cannot be answered, yet. Therefore, we wrote in the conclusions: “To date, it is unclear for most metabolites if observed changes arise from modified resorption from the intestines, modified production or metabolism in the maternal tissues, or their migration through the placenta”. It is indeed of high interest that we learn more about factors enabling homoeostasis or increase/decrease of specific parameters and of course about potential consequences if the demands for specific metabolites are not met. But these questions cannot be answered by our results.

Line 229: DHA is not increased in the last period of pregnancy. Actually, it should have increased in the last period of pregnancy, because it is very important for puppies. You should add mechanisms to the text about it. Why is the concentration decreased and not increased in the last trimester of pregnancy?

AU: Also here we might see the consequences of an increased uptake of DHA by the puppies, leading to decreased concentrations in maternal blood. We need much more specific studies – for example comparing the concentrations in blood serum of the mother with the ones in fetal serum or in amniotic fluid.

We suggest that we just describe these findings because underlying mechanisms are widely unknown.

Line 232: remove

AU: has been removed

Line 235: Why exactly did you measure arachidonic acid? What can this be indicative of in pregnant and lactating dogs. Could you please add such topics to the text? Please revise the rest of the discussion section based on what I wrote above. The discussion "increased/decreased in pregnancy in women, increased/decreased in our study" overshadows the quality of your study. Please include in the text the mechanisms by which the decrease or increase occurred. Include information in the discussion section, with studies of dogs or cats rather than women.

AU: Arachidonic acid was part of the metabolomics measurements and, therefore, included here. We are sorry to read that you find the way of discussion inappropriate. Our intention is to compare our results with other results from dogs. Since not much is known and potentially a comparison with results from other species might help to explain features in dogs and humans, we decided to use the actual approach. Would you suggest that we delete all comments on human metabolomic changes?

Line 237: AA

AU: has been changed

Line 237: remove

AU: has been removed

Statistical Analyses

Line 130: Why did you use the Friedman-Test? Why didn't you use parametric tests? Can you give a guiding explanation in the text about this?

AU: The statistical section was amended (lines 144 ff). The Friedman test was chosen because of 2 requirements for the analysis. First, we have a repeated measures problem, since every animal was measured 6 times (i.e. 6 time points). The Friedman Tests allow to account for this, thus comparing the changes in metabolites within each animal over the course of pregnancy. The second problem was the normality assumption. Since we measured 123 metabolites the normality assumption must be checked for every metabolite. This is not reliably possible with the limited number of observations we have. Therefore, a non-parametric test was chosen since it is more robust.

Why didn't you make a pairwise comparison of sampling days? Please add statistical analysis. Isn't it necessary to make a pairwise comparison of the parameters that Friedman-Test results are statistically significant?

Figure 1: Include pairwise comparisons of sampling days of parameters that multiple comparison is statistically significant.

Figure 2: Include pairwise comparisons of sampling days of parameters that multiple comparison is statistically significant.

AU: In our approach no post-hoc tests are needed. While the ANOVA/Friedman-Test is commonly used as a prerequisite for post-hoc tests, the ANOVA was developed as a fully independent statistical test. The null hypothesis is that there are no changes in metabolite levels within each animal over the course of the pregnancy. The alternative hypothesis being that there are metabolic changes. This is exactly what we wanted to test for. Thus, the test was chosen according to our scientific questions.

Line 192: P = 0.647 I guess there is no trend. There were individual high values in the data set. I don't think this means that there might be a trend.

AU: The effect of total fatty acids with P = 0.647 is a cumulative effect of all included fatty acids in this variable. Therefore, the changes observed for e.g. Docosahexaenoic acid, Arachidonic acid or Omega-3 influence the concentration of total fatty acids. Other fatty acids like Palmitic acid or Stearic acid dilute this effect. The change in total fatty acids is therefore a sum of its parts and is not an independent random variable. We think going from big (cumulative parameters) into small (specific parameters) is a reasonable and logical approach.

Thus, the p-values are not relevant for the biological interpretation of the observed changes. Additionally, p-values are not a measure of trend or effect size, please see the “The American Statistical Association’s Statement on p-Values” (https://doi.org/10.1080/00031305.2016.1154108) and non-significant p-values do not indicate no effect.

Line 193: P=????

AU: please see comment below

Line 199: Please give P value

AU: We omitted the p-values in the text, to avoid duplication of information, but more importantly because p-values have a limited interpretation for ‘omics data analysis. Classical statistical analysis assumes that the number of observations is a multiple of the number of independent variables. For high-dimensional data with lots of variables (123 metabolites) this is often not the case. Therefore, we used dimensionality reduction (k-means Clustering) to create 5 independent latent variables. This assumes that within a cluster, observed changes in each metabolite are not independent of each other. This is a common approach in ‘omics data analysis (https://doi.org/10.1093/aje/kwx016, https://doi.org/10.1186/1471-2105-12-253, https://doi.org/10.1186/1471-2105-13-24). We added this aspect to the statistical methods. Thank you for your comments, we realized that most of our goals and assumptions of the statistical analysis were not stated clearly and hope the new version is more transparent.

Figure Legends: Remove

AU: We suggest to not remove this legend to make it easier for the reader to see the used tests

Attachment

Submitted filename: Reviewer_responsePLOS_Metabolomics.docx

Decision Letter 1

Mükremin Ölmez

4 Apr 2023

Metabolomics during canine pregnancy and lactation

PONE-D-22-35093R1

Dear Dr. Bartel,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mükremin Ölmez

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Dear Authors,

I would like to express my disagreement with the use of certain statistical analysis methods in the manuscript. Furthermore, as I have previously noted in my corrections, there seems to be a lack of clear explanations for why certain parameters were analyzed. Perhaps you attempted to measure a series of measurements in dogs, but the purpose of this study remains unclear.

While the recent additions made to the Discussion section are a step in the right direction, I believe there is still room for improvement. Although the manuscript is now more coherent, the explanations for the statistical methods and parameter analyses require further elaboration.

As you have mentioned, conducting a more specific study on dogs would result in more precise data. Therefore, I encourage you to consider conducting a more focused study on this particular species.

Regarding the use of birthday sampling, I understand the importance of measuring metabolic changes from birth onwards. However, it may be more beneficial to consider postpartum measurements in carnivores at an earlier stage, as the metabolic changes may not be as significant during the later stages.

Thank you for your attention to these matters, and I look forward to seeing the progress of your work.

Best regards,

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

Mükremin Ölmez

12 Apr 2023

PONE-D-22-35093R1

Metabolomics during canine pregnancy and lactation

Dear Dr. Bartel:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mükremin Ölmez

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Metabolomics raw data.

    (CSV)

    Attachment

    Submitted filename: PONE-D-22-35093_reviewer.pdf 4.pdf

    Attachment

    Submitted filename: PONE-D-22-35093. Corr.pdf

    Attachment

    Submitted filename: Reviewer_responsePLOS_Metabolomics.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES